Con and Temporary: The Tipline for 7 February 2018

In addition to convincing the government that its $69 billion acquisition of Aetna does not run afoul of the antitrust laws, CVS Health must now defend a tying claim in federal court – or settle the lawsuit, pressure for which which could have been the plaintiff’s strategy for filing the complaint now.

Get unlimited access to all Global Competition Review content